News Focus Channel: 68th AACC Annual Scientific Meeting & Clinical Lab Expo

Research That Could Significantly Improve Treatment for Autism Unveiled at 69th AACC Annual Scientific Meeting

69th AACC Annual Scientific Meeting Press Program — Wed, 02 Aug 2017 09:30:00 EST

A team of researchers has demonstrated that children with autism spectrum disorder have a unique composition of gut bacteria and urinary metabolites compared with unaffected children. The research, revealed today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego, could lead to promising new treatment options for children with autism as well as earlier detection of the disorder.

Better Outcomes for Young Women Surviving Cancer

69th AACC Annual Scientific Meeting Press Program — Wed, 02 Aug 2017 03:05:57 EST

Reproductive health is not the same as sex ed," Teresa K. Woodruff, PhD, from the Feinberg School of Medicine, Northwestern University, reminded us in yesterday's plenary session, "Oncofertility: From Bench to Bedside to Babies." The war on cancer has been hard fought, with more young women than ever now surviving cancer but being faced with the possibility of infertility.

New Psychoactive Substances Challenge Detection

69th AACC Annual Scientific Meeting Press Program — Wed, 02 Aug 2017 03:05:39 EST

Anyone who walked into Monday's morning symposium, "Novel Psychoactive Substances (NPS) in Emergency Toxicology" thinking that NPS are not a growing threat to public health were quickly disavowed of that notion. Speakers Jennifer Colby, PhD, and Kai Li, MD, described various compounds, including the drug U-47700, which is a synthetic super-opioid that causes extreme euphoria and respiratory depression, frequently leading to adverse effects, including death.

Interesting Findings: Unexpected Discoveries Among the Posters

69th AACC Annual Scientific Meeting Press Program — Wed, 02 Aug 2017 03:05:24 EST

The 2017 AACC Annual Meeting Organizing Committee accepted 740 abstracts representing innovative scientific work from more than a dozen countries. Although every abstract will not receive distinguished recognition from the AACC Academy or the various AACC Divisions, highlighted here are several interesting studies that you may want to visit during this year's poster sessions. Posters are located in the upper level of the Sails Pavilion in the San Diego Convention Center.

Expert Advice on Picking the Correct Genetic Test

69th AACC Annual Scientific Meeting Press Program — Wed, 02 Aug 2017 03:05:14 EST

The amount of information gathered via next-generation sequencing has made the diagnosis of genetic disorders quicker and more accessible to clinicians than ever before, but with expanded testing options come questions about ordering the correct type of testing.

Is Laboratory Medicine Ready for Artificial Intelligence?

69th AACC Annual Scientific Meeting Press Program — Wed, 02 Aug 2017 03:05:03 EST

Some say that the invention of the abacus more than 2,500 years ago was the first step on the long road to artificial intelligence (AI). The reason why this simple calculator made of beads and wires is often called the precursor to the modern computer is because the principle--performing repeated calculations faster than the human brain--is the same. Now scientists are harnessing the speed of modern computers and programming them with cognitive algorithms and sophisticated decision trees to help solve complex medical problems. This rapidly advancing science was the focus yesterday of the Chair's Invited Session, "Is Artificial Intelligence in Genomics Ready for Prime Time?"

Two Innovative Methods Could Help to Predict Flu Outbreaks and Prevent the Spread of Antibiotic Resistance

Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC)) — Tue, 01 Aug 2017 14:30:00 EST

Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

Novel Studies Deliver Crucial Insight on Opioid and Overall Drug Abuse Trends in U.S., Canada

69th AACC Annual Scientific Meeting Press Program — Tue, 01 Aug 2017 09:30:00 EST

A new study shows that a change in policy placing more restrictions on all hydrocodone-containing drugs has successfully decreased the use of certain opioids such as Vicodin. This research and a second study illuminating regional drug use trends in Canada were announced today at the 69th AACC Annual Scientific Meeting in San Diego, and could help to guide future strategies for combatting addiction.

Findings That Could Lead to the First Blood Test for Kidney Cancer Presented at the 69th AACC Annual Scientific Meeting

Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC)) — Tue, 01 Aug 2017 09:30:00 EST

A new study has discovered that two microRNAs could be used to develop the first-ever blood test for kidney cancer as well as novel treatments for this condition. These findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

Novel Genetic Test Could Help Combat the Opioid Epidemic by Identifying Patients at Risk of Addiction

69th AACC Annual Scientific Meeting Press Program — Tue, 01 Aug 2017 09:30:00 EST

Researchers have shown that a new genetic test could potentially help stem the tide of the opioid epidemic by predicting which patients are at risk of abusing prescription opioids. These findings were presented for the first time at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

AACC Announces 2017 Corporate Supporter Award Winners; Thanks Organizations for Their Invaluable Support

69th AACC Annual Scientific Meeting Press Program — Tue, 01 Aug 2017 09:00:00 EST

AACC is pleased to announce the recipients of the AACC 2017 Top Corporate Supporter Awards. This year, AACC recognizes 46 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.

New Frontiers in Genomic Engineering, Oncofertility, Public Health, and the Digital Health Revolution to Be Explored at the 69th AACC Annual Scientific Meeting

69th AACC Annual Scientific Meeting Press Program — Sun, 30 Jul 2017 17:00:00 EST

At the 69th AACC Annual Scientific Meeting & Clinical Lab Expo--the premier global conference and exhibit for laboratory medicine--visionaries in the field will illuminate the pioneering research and technology paving the way for better clinical testing and patient care. From July 30-August 3 in San Diego, the meeting will feature more than 200 talks on a broad range of timely healthcare topics. Highlights of these include plenaries that explore transforming biology using CRISPR engineering and new applications for DNA sequencing; preserving fertility in young people with cancer; how clinical testing can help solve public health crises; and a session that uncovers the precision diagnostics that are creating a digital health revolution.

Protecting Valuable Inventory Throughout the Cold Chain Just Got Easier

2016 AACC Annual Meeting Press Program — Thu, 04 Aug 2016 14:05:22 EST

Tutela Monitoring Systems has your solution to mobile cold chain protection

Research on Zika, CRISPR, and Programmable Bio-Nano-Chips Draws 20,000 Attendees to 68th AACC Annual Scientific Meeting & Clinical Lab Expo

2016 AACC Annual Meeting Press Program — Thu, 04 Aug 2016 11:05:12 EST

AACC welcomed thousands of medical professionals and healthcare leaders at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia from July 31-August 4. The meeting featured pioneering advances in medical testing research and technology that will help patients get accurate diagnoses and more effective treatment. As of Wednesday, August 3, a total of 20,000 laboratory medicine professionals had registered for the meeting, which is a 14% increase over meeting attendance in 2015 and the highest number of attendees that have come to the meeting in the last four years. More attendees are expected today, the last day of the meeting.

Tutela Monitoring Systems - Introducing the Genesis II

2016 AACC Annual Meeting Press Program — Wed, 03 Aug 2016 14:10:55 EST

The Tutela Genesis II Temperature Monitoring System is the most intuitive and robust system yet from Tutela. Find out why so many have chosen Tutela to monitor their priceless inventory.

Advancing Patient Care through Laboratory Excellence: Beckman Coulter Showcases Integrated Product-Service Solutions at 2016 AACC Annual Scientific Meeting and Clinical Lab Expo

2016 AACC Annual Meeting Press Program — Wed, 03 Aug 2016 14:05:27 EST

Beckman Coulter Addresses Critical Factors for Clinical Laboratories to Move Healthcare Forward

GlycoMark, Inc. Partners with Diazyme Laboratories to Launch Comprehensive Panel for Diabetes Management

2016 AACC Annual Meeting Press Program — Wed, 03 Aug 2016 14:05:18 EST

GlycoMark, Inc. announced it has partnered with Diazyme Laboratories to offer the first diabetes panel to test three different measures of glycemic control on one specimen. The panel includes assays that measure both intermediate-term and long-term glucose averages (Diazyme's Glycated Serum Protein/GSP and Enzymatic HbA1c) along with GlycoMark--a test specifically related to hyperglycemia over a one- to two-week period. The announcement was made at the 68th AACC Annual Scientific Meeting and Clinical Lab Expo.

Beckman Coulter and Augusta University's Medical Center Sign Fifteen Year Agreement Collaborating on Innovative Methods to Improve Patient Outcomes

2016 AACC Annual Meeting Press Program — Wed, 03 Aug 2016 13:05:00 EST

The first of its kind alliance provides Augusta University's medical center with unprecedented access to the full suite of diagnostic products and world-class business services available from Beckman Coulter's parent company, Danaher Corporation.

Study Finds One in Five Pain or Rehab Patients Taking the Medication Gabapentin Without Prescription

Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC)) — Wed, 03 Aug 2016 10:30:00 EST

With increasing public attention to overdose deaths and misuse of prescription medications in the United States, researchers today presented the results of a new study looking at abuse and misuse of gabapentin, a medication used to treat seizures and relieve nerve pain often associated with shingles.

New Biochip-Based Blood Test Detects Elevated Risk for Alzheimer's Disease

Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC)) — Wed, 03 Aug 2016 09:30:00 EST

Researchers today unveiled results from a new blood test to help identify which patients are at an elevated risk of Alzheimer's disease. The findings, presented at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia, showed that the biochip test, which allows multiple tests to be run on one blood sample, was as accurate as existing molecular tests that analyze DNA.